Overview
- O'Donnell told Ana Navarro on the July 27 podcast that she spent a year each at 2.5 mg and 5 mg before nearly a year at 7.5 mg and that she plans one more upward change then will hold the dose.
- She says the regimen produced roughly a 60‑pound loss over three years and called the treatment life changing for quieting constant hunger and food thoughts.
- O'Donnell repeatedly said she never experienced common GLP‑1 side effects such as nausea, and she attributed that outcome to deliberately slow titration under medical supervision.
- The weight loss changed daily habits for her—she cut back on Diet Coke and sugar—and led to facial volume loss that prompted a facelift, which she has discussed publicly.
- She emphasized that Mounjaro is prescribed for type 2 diabetes and weight loss, urged lower prices so more people can access treatment, and framed her openness as a push against stigma around obesity.